*GG*
senior member
- Messages
- 6,389
- Location
- Concord, NH
A new study published by JAMA Internal Medicine poses a really important question to lawmakers and taxpayers alike.
Over the past five years, why has the US government spent $1 billion on a drug that is no more effective than alternatives that are tens of thousands of dollars cheaper per treatment?
The drug is called Acthar, and for the past year it has been the focus of a study by the Oregon Health and Science University School of Medicine and Oregon State that has been trying to understand why doctors keep prescribing it for ailments it has never been proved to treat effectively.
cont'd
https://flipboard.com/@flipboard/-t...journal-in-t/f-6f18c4eac7/businessinsider.com
Over the past five years, why has the US government spent $1 billion on a drug that is no more effective than alternatives that are tens of thousands of dollars cheaper per treatment?
The drug is called Acthar, and for the past year it has been the focus of a study by the Oregon Health and Science University School of Medicine and Oregon State that has been trying to understand why doctors keep prescribing it for ailments it has never been proved to treat effectively.
cont'd
https://flipboard.com/@flipboard/-t...journal-in-t/f-6f18c4eac7/businessinsider.com